AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
36,046,535
Share change
+1,371,250
Total reported value
$1,377,317,197
Put/Call ratio
239%
Price per share
$38.21
Number of holders
121
Value change
+$59,316,112
Number of buys
74
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q2 2018

As of 30 Jun 2018, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,046,535 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, VANGUARD GROUP INC, STATE STREET CORP, Versant Venture Management, LLC, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). This page lists 121 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.